BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8479113)

  • 1. Parathyroid gland function in chronic renal failure.
    Felsenfeld AJ; Llach F
    Kidney Int; 1993 Apr; 43(4):771-89. PubMed ID: 8479113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy.
    Felsenfeld AJ; Rodriguez M; Dunlay R; Llach F
    Nephrol Dial Transplant; 1991; 6(4):244-51. PubMed ID: 1881578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysteresis of the parathyroid hormone response to hypocalcemia in hemodialysis patients with low turnover aluminum bone disease.
    Felsenfeld AJ; Ross D; Rodriguez M
    J Am Soc Nephrol; 1991 Dec; 2(6):1136-43. PubMed ID: 1777594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
    Rodriguez M; Felsenfeld AJ; Williams C; Pederson JA; Llach F
    J Am Soc Nephrol; 1991 Nov; 2(5):1014-20. PubMed ID: 1760537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
    Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
    Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
    Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
    Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
    Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
    Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
    Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
    Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients.
    Borrego MJ; Martin-Malo A; Almaden Y; Rodriguez M; Aljama P; Felsenfeld AJ
    Am J Kidney Dis; 1999 Sep; 34(3):456-63. PubMed ID: 10469855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
    Malberti F; Farina M; Imbasciati E
    Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB; Goodman WG
    Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.
    Ouseph R; Leiser JD; Moe SM
    J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
    Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
    Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parathyroid function in patients on chronic intermittent hemodialysis (author's transl)].
    Augustin R; Hackeng WH
    Klin Wochenschr; 1977 Aug; 55(16):811-6. PubMed ID: 409876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.
    Dunlay R; Rodriguez M; Felsenfeld AJ; Llach F
    Kidney Int; 1989 Dec; 36(6):1093-8. PubMed ID: 2601258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.